Mainz Biomed NV (MYNZ)
0.67
+0.01
(+1.52%)
USD |
NASDAQ |
May 13, 16:00
0.6776
+0.01
(+1.13%)
After-Hours: 20:00
Mainz Biomed Profit Margin (Quarterly): -2.41K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.41K% |
| September 30, 2023 | -3.47K% |
| June 30, 2023 | -3.31K% |
| March 31, 2023 | -2.62K% |
| Date | Value |
|---|---|
| December 31, 2022 | -4.24K% |
| September 30, 2022 | -5.78K% |
| June 30, 2022 | -4.98K% |
| March 31, 2022 | -5.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.78K%
Minimum
Sep 2022
-2.41K%
Maximum
Dec 2023
-4.06K%
Average
-3.85K%
Median
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -4.89K% |
| InflaRx NV | -26.80K% |
| MorphoSys AG | 81.70% |
| BioNTech SE | -168.0% |
| Immatics NV | -164.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -368.8% |
| Return on Assets | -142.3% |
| Return on Invested Capital | -219.3% |
| Gross Profit Margin (Quarterly) | 62.74% |
| Operating Margin (Quarterly) | -3.17K% |
| Return on Net Operating Assets | -142.4% |